| 000 | 00890 a2200253 4500 | ||
|---|---|---|---|
| 005 | 20250517225007.0 | ||
| 264 | 0 | _c20190325 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1474-4457 | ||
| 024 | 7 |
_a10.1016/S1473-3099(18)30342-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGonçalves, Reggiani Vilela | |
| 245 | 0 | 0 |
_aChronic Chagas disease: therapeutic protocols and efficacy endpoints. _h[electronic resource] |
| 260 |
_bThe Lancet. Infectious diseases _c07 2018 |
||
| 300 |
_a719-720 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChagas Disease |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aNitroimidazoles |
| 700 | 1 | _aNovaes, Rômulo Dias | |
| 773 | 0 |
_tThe Lancet. Infectious diseases _gvol. 18 _gno. 7 _gp. 719-720 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S1473-3099(18)30342-6 _zAvailable from publisher's website |
| 999 |
_c28602724 _d28602724 |
||